Companies Dominating the Cellular Health Screening Landscape
- SpectraCell Laboratories Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Genova Diagnostics
- Immundiagnostik AG
- Quest Diagnostics
- Bio-Reference Laboratories Inc.
- QIAGEN NV
- Bloom Diagnostics
- Cell Science System Corporation
- Laboratory Corporation of American Holdings
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Cellular Health Screening Market in 2025 is evaluated at USD 3.48 billion.
The global market size was valued at over USD 3.24 billion in 2024 and is expected to expand at a CAGR of around 9.1%, surpassing USD 10.05 billion revenue by 2037.
North America industry revenue is projected to grow to USD 3.32 billion by 2037, fueled by increasing awareness about personalized medicines and growing government initiatives supporting preventive healthcare.
The major players in the market include of Quest Diagnostics, Bio-Reference Laboratories Inc., QIAGEN NV, Bloom Diagnostics, Cell Science System Corporation, Laboratory Corporation of American Holdings, and others.
